CRESEMBA™ now available in Canada for the treatment of invasive aspergillosis and invasive mucormycosis

Thursday, May 2, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

_________________________________________________________

1

CRESEMBA™ (isavuconazole) Product Monograph : AVIR Pharma Inc.; December 24, 2018 (http://avirpharma.com/pdf/Product-Monograph-Cresemba.pdf )

2

Cresemba® US prescribing information [Accessed: December 6, 2018] https://www.astellas.us/docs/cresemba.pdf

3

European Public Assessment Report (EPAR) Cresemba®: http://www.ema.europa.eu [Accessed:  April 30, 2019]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store